ALTERITY THERAPEUTICS
4.0850
21-May-25 09:23:02
15 minutes delayed
Stocks
-0.1150
-2.74%
Today's range
3.9457 - 4.2500
ISIN
N/A
Source
NASDAQ
-
Alterity Therapeutics Appoints Abby Macnish Niven as Chief Financial Officer
30 Sep 2024 06:35:00 By Nasdaq GlobeNewswire
-
23 Sep 2024 06:35:00 By Nasdaq GlobeNewswire
-
Appendix 4C – Q4 FY24 Quarterly Cash Flow Report
31 Jul 2024 06:35:00 By Nasdaq GlobeNewswire
-
Alterity Therapeutics to Present at MST Financial Webinar
24 Jul 2024 06:35:00 By Nasdaq GlobeNewswire
-
17 Jul 2024 06:35:00 By Nasdaq GlobeNewswire
-
17 Jul 2024 06:25:00 By Nasdaq GlobeNewswire
-
Alterity Therapeutics to Present at the MST Access ‘Hidden Gems in Life Sciences’ Webinar
12 Jun 2024 18:22:16 By Nasdaq GlobeNewswire
-
Alterity Therapeutics to Host Webcast Today on New Data from the bioMUSE Natural History Study
29 May 2024 18:21:24 By Nasdaq GlobeNewswire
-
08 May 2024 06:25:00 By Nasdaq GlobeNewswire
-
Appendix 4C – Q3 FY24 Quarterly Cash Flow Report
30 Apr 2024 06:25:00 By Nasdaq GlobeNewswire
-
29 Apr 2024 06:25:00 By Nasdaq GlobeNewswire
-
17 Apr 2024 06:25:00 By Nasdaq GlobeNewswire
-
Alterity Therapeutics to Present New Data on ATH434 at the World Orphan Drug Congress USA 2024
10 Apr 2024 06:25:00 By Nasdaq GlobeNewswire
-
Alterity Therapeutics Receives a A$3.9 Million Research & Development Tax Incentive Refund
26 Mar 2024 09:25:00 By Nasdaq GlobeNewswire
-
20 Feb 2024 09:25:00 By Nasdaq GlobeNewswire
-
06 Feb 2024 06:25:00 By Nasdaq GlobeNewswire
-
Alterity Therapeutics to Participate in the ShareCafe Hidden Gems Webinar This Week
29 Jan 2024 06:24:00 By Nasdaq GlobeNewswire
-
22 Jan 2024 06:25:00 By Nasdaq GlobeNewswire
-
Alterity Therapeutics Appoints Phillip Hains as Chief Financial Officer
20 Dec 2023 23:30:00 By Nasdaq GlobeNewswire
-
04 Dec 2023 15:35:00 By Nasdaq GlobeNewswire